Mimi Stokke Opdal

Mimi Stokke Opdal is an Associate Professor in the Department of Pharmacology at the University of Oslo's Faculty of Medicine. Her research primarily focuses on therapeutic drug monitoring and clinical toxicology, with particular expertise in hypertension treatment adherence, methadone pharmacology, and analytical method development for drug quantification. She maintains an active research profile with publications spanning from the 1990s to the present.

Dr. Opdal's research interests center on therapeutic drug monitoring (TDM), clinical toxicology, and pharmacokinetics. Her work has evolved from early studies on cardiac pharmacology and calcium channels to current research on medication adherence in hypertension treatment, methadone pharmacokinetics, and analytical method development for drug quantification. She has made significant contributions to understanding how serum drug concentrations can be used to assess medication adherence and optimize treatment outcomes, particularly in cardiovascular medicine.

Analysis of her recent publications (2011-2025) shows a clear focus on therapeutic drug monitoring applications in clinical practice. Her work spans hypertension management, methadone maintenance therapy, antiepileptic drugs, and forensic toxicology. A notable trend is her development and application of advanced analytical techniques (particularly UHPLC-MS/MS) for drug quantification in biological samples, which has enabled more precise therapeutic drug monitoring and improved understanding of medication adherence patterns.

Dr. Opdal is actively involved in the Therapeutic Drug Monitoring and Clinical Toxicology research group at the University of Oslo. Her collaborative approach is evident in her numerous multi-author publications involving researchers from various Norwegian hospitals and institutions. While specific grant information isn't provided in the available text, her extensive publication record in high-impact journals suggests successful grant acquisition supporting her research activities.

Her laboratory work focuses on analytical method development for drug quantification, particularly using UHPLC-MS/MS techniques. The research group appears to maintain strong clinical connections, conducting studies in emergency departments, hypertension clinics, and with patients in methadone maintenance programs. This translational approach bridges laboratory analytical science with direct clinical applications.